We are live on ! Find out more
TI

Turner Investments Portfolio holdings

AUM $134K
1-Year Est. Return 49.03%
This Fund
S&P 500
This Quarter Est. Return
+0.63%
1 Year Est. Return
-49.03%
3 Year Est. Return
+6.36%
5 Year Est. Return
+75.79%
10 Year Est. Return
AUM
$369M
AUM Growth
-$114M
Cap. Flow
-$97.1M
Cap. Flow %
-26.31%
Top 10 Hldgs %
18.38%
Holding
302
New
88
Increased
47
Reduced
69
Closed
95

Top Sells

Rank Stock Value
1
LLY icon
Eli Lilly
LLY
+$6.93M
2
NVS icon
Novartis
NVS
+$6.11M
3
APTV icon
Aptiv
APTV
+$5.73M
4
BFH icon
Bread Financial
BFH
+$5.18M
5
NBR icon
Nabors Industries
NBR
+$4.96M

Sector Composition

Rank Sector Weight
1 Healthcare 31%
2 Technology 24.95%
3 Industrials 8.8%
4 Consumer Discretionary 8.28%
5 Communication Services 7.89%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AMGN icon
201
Amgen
AMGN
$218B
$26K 0.01%
+175
New +$26K
LLY icon
202
Eli Lilly
LLY
$1.05T
$22K 0.01%
300
-91,590
-100% -$6.93M
ATRS
203
DELISTED
Antares Pharma, Inc.
ATRS
$17K ﹤0.01%
20,000
-555,000
-97% -$537K
ICD
204
DELISTED
Independence Contract Drilling, Inc.
ICD
$14K ﹤0.01%
150
-600
-80% -$50.6K
NDRM
205
DELISTED
NeuroDerm Ltd. Ordinary Shares
NDRM
$14K ﹤0.01%
+1,000
New +$13.5K
BHC icon
206
Bausch Health
BHC
$2.27B
$9K ﹤0.01%
+350
New +$25.9K
AKTX
207
Akari Therapeutics
AKTX
$13.3M
-40
Closed -$415K
ADBE icon
208
Adobe
ADBE
$101B
-23,610
Closed -$2.22M
ALK icon
209
Alaska Air
ALK
$5.75B
-25,000
Closed -$2.01M
ALKS icon
210
Alkermes
ALKS
$8.13B
-4,500
Closed -$357K
AME icon
211
Ametek
AME
$58B
-82,760
Closed -$4.43M
AMN icon
212
AMN Healthcare
AMN
$1.24B
-20,000
Closed -$621K
AMPH icon
213
Amphastar Pharmaceuticals
AMPH
$869M
-89,750
Closed -$1.28M
ANET icon
214
Arista Networks
ANET
$245B
-288,000
Closed -$1.4M
APTV icon
215
Aptiv
APTV
$9.92B
-66,870
Closed -$5.73M
EFOR
216
Everforth Inc
EFOR
$1.3B
-16,500
Closed -$742K
BA icon
217
Boeing
BA
$187B
-14,400
Closed -$2.08M
BAC icon
218
Bank of America
BAC
$442B
-90,000
Closed -$1.51M
BFH icon
219
Bread Financial
BFH
$4.53B
-23,456
Closed -$5.18M
BNY
220
Bank of New York Mellon
BNY
$108B
-30,000
Closed -$1.24M
BLK icon
221
Blackrock
BLK
$175B
-3,000
Closed -$1.02M
CAH icon
222
Cardinal Health
CAH
$55B
-11,100
Closed -$991K
CFG icon
223
Citizens Financial Group
CFG
$30.8B
-31,000
Closed -$812K
CRDF icon
224
Cardiff Oncology
CRDF
$74.1M
-49
Closed -$19K
CYBR
225
DELISTED
CyberArk
CYBR
-1,500
Closed -$68K

Similar funds

Turner Investments's Q1 2016 Portfolio in Review

As of Q1 2016, Turner Investments held 302 positions worth $369M, down 24% from $483M the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Turner Investments withdrew a net $97.1M in Q1 2016, closing 95 positions and reducing 69 holdings. Its most notable exit was Aptiv, an estimated $5.73M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 31% of assets, down from 36% a quarter earlier, followed by Technology and Industrials.

Against the trend, Turner Investments opened a new position in Edwards Lifesciences worth $4.87M.

  • Turner Investments's largest Q1 2016 buy was Edwards Lifesciences: 165,450 shares worth $4.87M.
  • Turner Investments added most to SolarEdge in Q1 2016, an estimated $4.14M increase.
  • Turner Investments's biggest Q1 2016 reduction was Eli Lilly, cutting an estimated $6.93M.
  • Turner Investments fully exited Aptiv in Q1 2016, selling an estimated $5.73M.
  • Turner Investments's ten largest holdings make up 18% of its $369M portfolio in Q1 2016.
  • Turner Investments opened 88 new positions and closed 95 in Q1 2016.
  • Turner Investments's portfolio value fell 24% quarter-over-quarter to $369M.

Based on Turner Investments's 13F filing for Q1 2016, filed 13 May 2016.